MadhuriVusirikalaMD

Hematology • Dallas, TX

Hematologic Oncology

Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to view full profile

Dr. Vusirikala is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vusirikala's full profile

Already have an account?

Office
2201 Inwood Rd
Dallas, TX 75235
Phone+1 214-645-4673

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1996 - 1999
SUNY Upstate Medical UniversityResidency, Internal Medicine, 1993 - 1996
Lady Hardinge Medical CollegeClass of 1992

Certifications & Licensure

TX State Medical License 2006 - 2025
TN State Medical License 2000 - 2006
PA State Medical License 1996 - 2000
WI State Medical License 1995 - 1997

Clinical Trials

A Study to Compare T-Guard vs Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-vs-Host Disease (BMT CTN 2002) Start of enrollment: 2022 Jun 16
Terminated
Phase 3
Roles: Contact

Publications & Presentations

PubMed

Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia.
Sameem M Abedin, Guru Subramanian Guru Murthy, Mehdi Hamadani, Laura C Michaelis, Karen-Sue Carlson
Leukemia. 2025-02-15
Randomized Phase III SIERRA Trial ofI-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.
Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, Hannah Choe, Mark R Litzow
Journal of Clinical Oncology. 2025-01-10
Anti-Spike Antibody Responses in Allogeneic Stem Cell Transplant Recipients to Two Doses of COVID-19 mRNA Vaccination: A Retrospective, Single-Center Analysis.
Jaime L Shahan, Robert H Collins, Prapti Patel, Yazan F Madanat, Madhuri Vusirikala
Journal of the Advanced Practitioner in Oncology. 2023-07-01

Press Mentions

Actinium Expands Clinical Leadership Team to Support Key Development Programs for Iomab-B and Actimab-AOctober 27th, 2022